Used in scans for known hepatocellular carcinoma (HCC). Sold as Lipiodol. Every FDA application for this active ingredient.
As of Nov 14, 2026, FDA lists 1 application for Ethiodized Oil (sold as Lipiodol), first approved Mar 31, 1954, with 1 new use approved and 0 published complete response letters.
| Observation Study on the Efficacy and Safety of Hepatic Artery Embolization Combined With Radiofrequency Ablation for Hepatic Hemangioma: The Impact of Different Treatment IntervalsHepatic Hemangioma · Beijing Tiantan Hospital | — | Not yet recruiting | Nov 5, 2026 |
| Prostatic Artery Embolization Using Histoacryl as a Novel Embolizing Agent for Treatment of BPHBenign Prostatic Hyperplasia, Lower Urinary Tract Symptoms · Assiut University | Not applicable | Not yet recruiting | Oct 29, 2026 |
| Cyanoacrylate Glue Versus Absorbable Gelatin Sponge for Gastric VaricesGastric Varices Bleeding, Gastric Varices · Unity Health Toronto | Not applicable | Not yet recruiting | Jul 13, 2026 |
| HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)Hepatocellular Carcinoma · Binkui Li | Phase 3 | Recruiting | May 18, 2026 |
| Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCCInitially Unresectable Hepatocellular Carcinoma · Hong Wu | Not applicable | Not yet recruiting | Mar 18, 2026 |
| Achilles Tendinopathy EmbolizationAchilles Tendinopathy (AT) · Joint & Vascular Institute | Phase 1 | Recruiting | Mar 17, 2026 |
| Adjuvant TACE in HCC With High-risk Recurrence FactorsHepatocellular Carcinoma, Adjuvant · Guangxi Medical University | Phase 3 | Recruiting | Feb 18, 2026 |
| Lateral Plantar Artery Embolization For Plantar FasciitisPlantar Fasciitis, Chronic, Plantar Fasciitis · Joint & Vascular Institute | Phase 1 | Recruiting | Feb 9, 2026 |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
